Viability of lactobacillus acidophilus in various vaginal tablet formulations

Daru

Volumn 14, Issue 4, 2006, Pages 172-177

  Fazeli, M R ^a   Toliyat, T ^a   Samadi, N ^a   Hajjaran, S ^a   Jamalifar, H ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lactobacillus acidophilus; Probiotic; Vaginal tablet

Indexed keywords

AGENTS USED INTRAVAGINALLY; CARBOMER; CITRIC ACID; PROBIOTIC AGENT;

ARTICLE; CELL VIABILITY; CHELATION; DRUG FORMULATION; LACTOBACILLUS ACIDOPHILUS; NONHUMAN; SLOW DRUG RELEASE;

EID: 33846892579     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Elmer GM, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. J Am Med Assoc 1996; 275: 870-876.
2. Charteris WP, Kelly PM, Morelli L, Collins JK. The role and therapeutic potential of Lactobacillus species in female urogenital tract infection. Microecol Ther 1997; 26: 59-96.
3. Nezdarilova J. Interaction between vaginal Lactobacilli and other microorganisms in the vaginal flora. Scripta Medica 1992; 65: 135-141.
4. Sobel JD. Vaginitis and vaginal flora. Curr Opin Infect Dis 1996; 9: 42-47.
5. Larsen B. Vaginal flora in health and disease. Clin Obstet Gyneocol 1993; 36: 107-121.
6. Mehta A, Talwalker J, Shetty CV, Motashaw ND. Microbial flora of the vagina. Microecol Ther 1995; 23: 1-7.
7. Puapermpoonsiri S, Kato N, Watanabe K, Ueno K, Chongsomchai C, Lumbiganon P. Vaginal microflora associated with bacterial vaginosis in Japanese and Thai pregnant women. Clin Infect Dis 1996; 23: 748-752.
8. Blackwell AL, Fox AR, Phillips J, Barlow D. Anaerobic vaginosis (non-specific vaginitis): clinical, microbiological, and therapeutic findings. Lancet 1983; 2: 1379-1382.
9. Boris S, Suarez JE, Vazquez F, Barbes C. Adherence of human vaginal Lactobacilli to epithelial vaginal cells and interaction with uropathogens. Infect Immun 1998; 66: 1985-1989.
10. Mardh PA, Westrom L. Adherence of bacteria to vaginal epithelial cells. Infect Immun 1979; 13: 661-666.
11. Chan RCY, Reid G, Irvin RT, Bruce AW, Costerton JW. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragment. Infect Immun 1985; 47: 84-89.
12. Eschenbach DA, Davick PR, Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, Holmer KK. Prevalence of hydrogen-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin. Microbiol 1989; 27: 251-256.
13. Hawes SE, Hiller SL, Benedetti J, Stevens CE, Koutsky LA, Wolner-Hanssen P, Holmes KK. Hydrogen peroxide-producing and acquisition of vaginal infections. J Infect Dis 1996; 174: 1058-1063.
14. 2-generating lactobacilli. J Infect Dis 1991; 164: 94-100.
15. Reid G, McGroarty JA, Angotti R, Cook RL. Lactobacillus inhibitor production against Escherichia coli and coagregation ability with uropathogens. Can J Microbiol 1985; 34: 344-351.
16. Boris S, Barbes C. Role played by Lactobacilli in controlling the population of vaginal pathogens. Microb Infect 2000; 2: 543-546.
17. Sieber R, Dietz U. Lactobacillus acidophilus and yogurt in the prevention and therapy of bacterial vaginosis. Int Dairy J 1998; 8: 599-607.
18. Mombeli B, Gismonda M. The use of probiotics in medical practice. Int J antimicrob agents 2000; 16: 531-536.
19. Piard JC, Desmazeaud M. Inhibition factors produced by lactic acid bacteria. Bacteriocins and other antibacterial substances. Lait 1992; 72: 113-142.
20. Hallen A, Jarstrand C, Pahlson C. Treatment of bacterial vaginosis with lactobacilli. Sex Trans Dis 1992; 19: 146-148.
21. Parent D, Bossens M, Bayot D, Kirkpatric C, Graf F, Wilkinson FE, Keiser RP. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and allow dose of esteriol: a placebo-controlled multi centric clinical trial. Arzneim Forsch 1996; 46: 68-73.
22. Maggi L, Brigid P, Matteuzzi D, Conte U. Pharmaceutical formulations for the vaginal administration of viable microorganisms. Eur J Pharm Biopharm 1994; 40: 176-178.
23. Mastromarino P, Brigidi P, Macchia S, Maggi L, Pirovano F, Trinchieri V, Conte U, Matteuzzi D. Characterization and selection of Lactobacillus strains for the preparation of vaginal tablets. J Appl Microb 2002; 93: 884-893.
24. Shalev E, Battino S, Weiner E, Colodner R, Keness Y. Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996; 5: 593-596.
25. British Pharmacopoeia. London: The Stationary Office; 1998. p. A188-189.
26. Maggi L, Mastromaria P, Macchia S, Brigid P, Pirovano F, Matteuzzi D, Conte U. Technological and biological evaluation of tablets containing different of lactobacilli for vaginal administration. Eur J Pharm Biopharm 2000; 50: 389-395.
27. Cavalier Ved. Vesely, Renata Maria Anna, De Simone, Claudio, inventors. Pharmaceutical compositions containing Lactobacilli for treatment of vaginal infections and related method. US Patent 6,277,370. 2001 Aug 21.
28. Phillips CA. The effect of citric acid, lactic acid, sodium citrate and sodium lactate, alone and in combination with nicin, on the growth of bacteria. Lett Appl Microb 1999; 29: 424-428.